Skip to main content
. Author manuscript; available in PMC: 2009 Sep 2.
Published in final edited form as: Vaccine. 2008 Jul 18;26(37):4795–4808. doi: 10.1016/j.vaccine.2008.07.002

Table 6.

HPV positivity and cervical neoplasia by age among sexually experienced women*

HC2 PCR HPV16 HPV18 Other oncogenic** Non oncogenic Cytology LSIL Cytology HSIL Histology CIN 1 Histology CIN 2+
AGE N* % Positive % Positive % % % %


18 717 36.8 53.7 7.9 2.4 34.6 20.2 16.6 1.1 1.0 0.1
19 796 38.7 53.1 9.8 3.6 31.9 16.3 16.0 0.8 0.3 0.4
20 769 37.7 51.5 7.4 4.3 29.5 15.9 12.5 1.2 1.0 0.3
21 689 37.9 52.8 11.8 3.6 33.7 18.7 15.7 1.6 0.7 0.6
22 765 33.2 51.1 7.7 2.1 29.7 14.4 10.5 2.2 0.5 0.8
23 738 31.5 46.7 6.8 4.5 28.3 13.4 10.7 2.2 0.4 1.1
24 714 33.5 48.9 8.3 2.0 29.6 12.2 11.5 3.0 1.3 1.1
25 683 25.9 41.7 6.9 3.1 25.3 11.6 8.0 3.3 1.0 1.2
Total 5871 34.5 50.0 8.3 3.2 30.3 15.3 12.7 1.9 0.8 0.7
*

The numbers of results for each test are slightly different

**

Includes HPV 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68